1 |
YAN R, LI W, YIN L, et al. Cardiovascular diseases and risk-factor burden in urban and rural communities in high-, middle-, and low-income regions of China: A large community-based epidemiological study[J]. J Am Heart Assoc, 2017, 6(2):pii: .
|
2 |
HWANG I C, KIM J Y, KIM J H, et al. Therapeutic potential of a novel necrosis inhibitor, 7-amino-indole, in myocardial ischemia-reperfusion injury[J]. Hypertension, 2018, 71(6):1143-1155.
|
3 |
TIRE Y, SARKILAR G, ESEN H, et al. The effect of intrathecal sufentanil preconditioning against myocardial ischemia-reperfusion injury[J]. Bratisl Lek Listy, 2018, 119(4):240-244.
|
4 |
WU Q, SHANG Y, BAI Y, et al. Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis[J]. Cell Cycle, 2021, 20(4):383-391.
|
5 |
XIONG W, QU Y, CHEN H, et al. Insight into long noncoding RNA-miRNA-mRNA axes in myocardial ischemia-reperfusion injury: the implications for mechanism and therapy[J].Epigenomics,2019,11(15):119.
|
6 |
赵智慧,白香花,何金玲,等.lncRNA-MALAT1/miRNA-145在舒芬太尼预处理减轻大鼠心肌缺血-再灌注损伤中的作用[J]. 临床麻醉学杂志, 2020, 36(4):387-391.
|
7 |
XU X Z, LUO B, XIAO Y, et al. Effects of lncRNA MALAT1-mediated β-catenin signaling pathway on myocardial cell apoptosis in rats with myocardial ischemia/reperfusion injury[J]. Eur Rev Med Pharmacol Sci, 2019, 23(21): 9557-9565.
|
8 |
SHI Y L, WANG Q, WEI J C. Influence of lncRNA-MALAT1 on neuronal apoptosis in rats with cerebral infarction through regulating the ERK/MAPK signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23(18):8039-8048.
|
9 |
KE J, YAO B, LI T, et al. A2 Adenosine receptor-mediated cardioprotection against reperfusion injury in rat hearts is associated with autophagy downregulation[J]. J Cardiovasc Pharmacol, 2015, 66(1):25-34.
|
10 |
KONG F, JIN J, LV X, et al. Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression[J]. Biomed Pharmacother, 2019, 109:716-725.
|
11 |
MA M, HUI J, ZHANG Q Y, et al. Long non-coding RNA nuclear-enriched abundant transcript 1 inhibition blunts myocardial ischemia reperfusion injury via autophagic flux arrest and apoptosis in streptozotocin-induced diabetic rats[J]. Atherosclerosis, 2018, 277:113-122.
|
12 |
HU X, LIU B, WU P, et al. LncRNA Oprm1 overexpression attenuates myocardial ischemia/reperfusion injury by increasing endogenous hydrogen sulfide via Oprm1/miR-30b-5p/CSE axis[J]. Life Sci, 2020, 254:117699.
|
13 |
RUAN Z, WANG S, YU W, et al. LncRNA MALAT1 aggravates inflammation response through regulating PTGS2 by targeting miR-26b in myocardial ischemia-reperfusion injury[J]. Int J Cardiol, 2019, 288:122.
|
14 |
ZHAO Z H, HAO W, MENG Q T, et al. Long non-coding RNA MALAT1 functions as a mediator in cardioprotective effects of fentanyl in myocardial ischemia-reperfusion injury[J]. Cell Biol Int, 2017,41(1):62-70.
|
15 |
SUN T, CHENG Y T, YAN L X, et al. LncRNA MALAT1 knockdown alleviates myocardial apoptosis in rats with myocardial ischemia-reperfusion through activating PI3K/AKT signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23(23):10523-10531.
|
16 |
焦浩淼,崔 静,高 歌,等.表观调控蛋白BRD4及其抑制剂在心肌纤维化中的研究进展[J].郑州大学学报(医学版),2021,56(2):211-216.
|
17 |
张 凌,张 旋,程 峣,等.miR-1306-5p 靶向水通道蛋白1对糖尿病心肌病变的调控作用[J].郑州大学学报(医学版),2021,56(2):236-241.
|
18 |
卞静, 温琳琼, 初巍巍, 等. 银杏酮酯预处理对心肌缺血再灌注大鼠心肌细胞凋亡的影响[J]. 解剖科学进展, 2019, 25(1):74-76,83.
|
19 |
CHEN X Y, CHEN Y, QU C J, et al. Vitamin C induces human melanoma A375 cell apoptosis via Bax- and Bcl-2-mediated mitochondrial pathways[J]. Oncol Lett, 2019,18(4):3880-3886.
|
20 |
孙玉芹. 羟基红花黄色素A调控线粒体抗心肌缺血-再灌注损伤作用的实验研究[D].长春: 吉林大学, 2012.
|
21 |
孟庆莉, 顾红燕, 王淑梅, 等. 柿叶提取物通过MAPK/ERK1/2通路减轻心肌缺血再灌注损伤[J]. 临床和实验医学杂志, 2019, 18(12):1233-1238.
|
22 |
ZHENG S, WANG Y B, YANG Y L, et al. LncRNA MALAT1 inhibits osteogenic differentiation of mesenchymal stem cells in osteoporosis rats through MAPK signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23 (11):4609-4617.
|
23 |
WANG S, ZHU Y, QIU R. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway[J]. Biomed Pharmacother, 2018,104:712-717.
|